Skip to main content
Clinical Trials/NCT05600166
NCT05600166
Not yet recruiting
Not Applicable

A Prospective Cohort Study Evaluating the Efficacy of a Double-layer Artificial Dermal Repair Material Combined With Growth Factors for Exposed Tendon Wounds

Wang xingang0 sites110 target enrollmentNovember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Open Wound of Hip With Tendon Involvement
Sponsor
Wang xingang
Enrollment
110
Primary Endpoint
Wound closure evaluation
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

Compared with the combination of double-layer artificial dermal repair materials combined with growth factors, and the treatment methods using double-layer artificial dermal repair materials, the time and effect of the two treatment regimens on the function and appearance of wound repair with exposed tendon were different, as well as the medical costs.

Detailed Description

This study used a prospective cohort study to select all patients who met the inclusion criteria in six hospitals within six months after the start of the trial, including no less than 55 patients receiving artificial dermis combined with growth factor and no less than 110 patients receiving simple artificial dermal treatment, and the cumulative number of patients was not less than 110 patients, to compare the time and effect of the two treatment options on the functional and cosmetic restoration of upper limb wound repair with exposed tendons.

Registry
clinicaltrials.gov
Start Date
November 1, 2022
End Date
October 31, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Wang xingang
Responsible Party
Sponsor Investigator
Principal Investigator

Wang xingang

Deputy Director

Second Affiliated Hospital, School of Medicine, Zhejiang University

Eligibility Criteria

Inclusion Criteria

  • Elbow joint to fingertip area, soft tissue defect accompanied by tendon exposed fresh wound, tendon exposed wound area of 2\~20cm2, wound area 5-600cm2, need to transplant autologous skin;
  • Incomplete aponeurosis;
  • Voluntarily sign the informed consent form. For persons with no or limited capacity for civil conduct, obtain the consent of their guardians and sign an informed consent form.

Exclusion Criteria

  • Wound infection or suspected osteomyelitis;
  • Chronic wounds;
  • More than 2/3 of the exposed tendons are suspended on the wound surface;
  • Those with serious primary diseases such as cardiovascular and cerebrovascular, liver and kidney and hematopoietic system, which cannot be treated by surgery;
  • Those who are allergic to collagen and chondroitin sulfate;
  • Other persons that the investigator deems unsuitable.

Outcomes

Primary Outcomes

Wound closure evaluation

Time Frame: 7 days after the patient implanted the autologous blade thick skin tablet

One week after transplantation of the autologous epidermis, the survival rate of skin grafting on the exposed tendon wound is localized.

Functional evaluation

Time Frame: 6 months after surgery

Range of motion

Appearance evaluation

Time Frame: 6 months after surgery

VSS(Vancouver scar scale) score of the supply area.About scars, color 0\~3 points; Thickness 0\~4 minutes; Vascular distribution 0\~3 points; Softness: 0\~5 points. All the points are added together, the smaller the better.

Similar Trials